MEN1 and hypophysitis: Thus, at 21 months of age 31.3% of PBS-treated Men1+/− mice (10/32) had pituitary NETs at least 10 mm3, whereas only 6.3% of pasireotide-treated Men1+/− mice (2/32) had pituitary NETs at least 10 mm3 (P < .01, Fisher's exact test).